Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects

被引：0
作者：
Hong Zhang
Qingmei Li
Xiaoxue Zhu
Cuiyun Li
Xiaojiao Li
Chengjiao Liu
Yue Hu
Guiling Chen
Haijing Wei
Jing Wang
Zhenwei Shen
Yanhua Ding
机构：
[1] The First Hospital of Jilin University,Phase I Clinical Research Center
[2] The First Hospital of Jilin University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 82卷
关键词：
Bevacizumab; Biosimilar; Immunogenicity; Pharmacokinetics; Inter-subject variability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：615 / 623
页数：8
相关论文
共 50 条
  • [21] COMPARATIVE BIOEQUIVALENCE AND PHARMACOKINETICS OF CIPROFLOXACIN IN HEALTHY MALE SUBJECTS
    Khan, Muhammad Khalid
    Khan, Muhammad Farid
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 22 (01) : 1 - 7
  • [22] A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects
    Liu, Ya-nan
    Huang, Jie
    Guo, Can
    Yang, Shuang
    Ye, Ling
    Wu, Shu-ting
    Zhang, Xing-fei
    Yang, Xiao-yan
    Han, Cui-cui
    Pei, Qi
    Huang, Lu
    He, Qing-nan
    Yang, Guo-ping
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 555 - 562
  • [23] A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects
    Ya-nan Liu
    Jie Huang
    Can Guo
    Shuang Yang
    Ling Ye
    Shu-ting Wu
    Xing-fei Zhang
    Xiao-yan Yang
    Cui-cui Han
    Qi Pei
    Lu Huang
    Qing-nan He
    Guo-ping Yang
    [J]. Cancer Chemotherapy and Pharmacology, 2020, 85 : 555 - 562
  • [24] Dose Proportionality and Pharmacokinetics of Eplerenone in Healthy Chinese Subjects
    Chen, J.
    Jiang, B.
    Lou, H.
    Xu, Y.
    Shao, R.
    Ruan, Z.
    [J]. DRUG RESEARCH, 2016, 66 (03) : 154 - 159
  • [25] Comparison of Pharmacokinetics of Aprepitant in Healthy Chinese and Caucasian Subjects
    Yang, Meng-Jie
    Xu, Hong-Rong
    Li, Hui
    Chen, Wei-Li
    Yuan, Fei
    Li, Xue-Ning
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1219 - 1226
  • [26] Pharmacokinetics, safety and tolerance of single- and multiple-dose adefovir dipivoxil in healthy Chinese subjects
    Sun, De-qing
    Wang, Hai-sheng
    Ni, Mei-yuan
    Wang, Ben-jie
    Guo, Rui-chen
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (01) : 15 - 23
  • [27] The Pharmacogenetic Variability Associated with the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects: A National Multicenter Exploratory Study
    Liu, Zhiyan
    Xie, Qiufen
    Zhao, Xia
    Tan, Yunlong
    Wang, Wenping
    Cao, Yu
    Wei, Xiaohua
    Mu, Guangyan
    Zhang, Hanxu
    Zhou, Shuang
    Wang, Xiaobin
    Cao, Ying
    Li, Xin
    Chen, Song
    Cao, Duanwen
    Cui, Yimin
    Xiang, Qian
    [J]. CLINICAL THERAPEUTICS, 2024, 46 (04) : 313 - 321
  • [28] Pharmacokinetics and Safety of Enzalutamide in Healthy Chinese Male Volunteers
    Liu, Yan-Mei
    Wu, Peggy
    Fukushi, Risa
    Yamada, Shunsuke
    Chen, Qian
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (02) : 261 - 268
  • [29] A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects
    Jia Xu
    Junyou Ge
    Yaling Li
    Shulin Liu
    Sicong Li
    Jing Si
    Juncheng Liu
    Xiaoxue Zhu
    Yanhua Ding
    [J]. Advances in Therapy, 2025, 42 (6) : 2797 - 2807
  • [30] The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects
    Small, David S.
    Kothare, Prajakti
    Yuen, Eunice
    Lachno, D. Richard
    Li, Ying G.
    Winters, Kenneth J.
    Farid, Nagy A.
    Ni, Lan
    Jakubowski, Joseph A.
    Salazar, Daniel E.
    Thieu, Vivian T.
    Payne, Christopher D.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (02) : 127 - 135
12345